Cargando…
P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428975/ http://dx.doi.org/10.1097/01.HS9.0000846648.34152.68 |
| _version_ | 1784779287892590592 |
|---|---|
| author | Quach, H. Parmar, G. Ocio, E. M. Prince, H. M. Oriol, A. Tsukada, N. Sunami, K. Bories, P. Karanes, C. Madan, S. Semiond, D. Inchauspe, M. Macé, S. Musholt, P. B. Suzan, F. Moreau, P. |
| author_facet | Quach, H. Parmar, G. Ocio, E. M. Prince, H. M. Oriol, A. Tsukada, N. Sunami, K. Bories, P. Karanes, C. Madan, S. Semiond, D. Inchauspe, M. Macé, S. Musholt, P. B. Suzan, F. Moreau, P. |
| author_sort | Quach, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428975 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289752022-08-31 P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS Quach, H. Parmar, G. Ocio, E. M. Prince, H. M. Oriol, A. Tsukada, N. Sunami, K. Bories, P. Karanes, C. Madan, S. Semiond, D. Inchauspe, M. Macé, S. Musholt, P. B. Suzan, F. Moreau, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428975/ http://dx.doi.org/10.1097/01.HS9.0000846648.34152.68 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Quach, H. Parmar, G. Ocio, E. M. Prince, H. M. Oriol, A. Tsukada, N. Sunami, K. Bories, P. Karanes, C. Madan, S. Semiond, D. Inchauspe, M. Macé, S. Musholt, P. B. Suzan, F. Moreau, P. P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title | P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title_full | P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title_fullStr | P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title_full_unstemmed | P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title_short | P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM PHASE 1B STUDY RESULTS |
| title_sort | p945: subcutaneous isatuximab administration by an on-body delivery system in combination with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: interim phase 1b study results |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428975/ http://dx.doi.org/10.1097/01.HS9.0000846648.34152.68 |
| work_keys_str_mv | AT quachh p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT parmarg p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT ocioem p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT princehm p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT oriola p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT tsukadan p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT sunamik p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT boriesp p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT karanesc p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT madans p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT semiondd p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT inchauspem p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT maces p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT musholtpb p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT suzanf p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults AT moreaup p945subcutaneousisatuximabadministrationbyanonbodydeliverysystemincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyelomapatientsinterimphase1bstudyresults |